ASTEC LIFE SCIENCES - QUARTERLY RESULTS - Q4 FY 20

ASTEC LIFE SCIENCES

QUARTERLY RESULTS

Q4 FY 20

Astec Lifesciences (in Rs. Cr.)	Mar '20	Dec '19	Sep '19	Jun '19	Mar '19	YOY	QOQ
Net Sales	180.57	124.83	140.21	76.99	133.76	35	44.65
Raw Materials	101.17	90.15	85.18	56.93	64.32	57.29	12.22
Increase in Stocks	10.66	-10.02	9.87	-5.78	28.2	-62.2	-206.39
Employees Cost	8.6	7.47	7.54	6.32	5.66	51.94	15.13
Depreciation	6.15	5.78	5.68	5.56	5.48	12.23	6.4
Other Expenses	17.07	16.4	22.37	13.13	12.5	36.56	4.09
P B T	39.63	15.61	7.83	-1.72	20.22	95.99	153.88
Tax	8.45	3.44	2.54	-0.61	7.49	12.82	145.64
N P T	31.18	12.16	5.28	-1.11	12.72	145.1	156.4
Equity ON FV 10	19.57	19.57	19.56	19.56	19.55	0.1	0
Basic EPS	15.94	6.22	2.7	-0.57	6.5	145.23	156.27
Diluted EPS	15.93	6.21	2.7	-0.57	6.5	145.08	156.52
May 7, 13:44MP		548.80 26.40 (5.05%)
Volume		515,856
PE		8.578125
52 Wk L/H	305	585
TECHNICAL RATING					Community Sentiments
Very Bullish					89% BUY
Moving Averages	Bullish				11% SELL
Technical Indicators	Bullish				0% HOLD
Moving Averages Crossovers	Bullish
Market Cap (Rs Cr.)		1065.50
P/E		22.4
Book Value (Rs)		127
Dividend (%)		15
Industry P/E		40.1
EPS (TTM)		24.26
Price/Book		4.28
Dividend Yield.(%)		0.28
Face Value (RS)		10
Deliverables (%)		60.79
* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive. Share Holding Pattern in (%) Standalone September 2019 June 2019 March 2019 December 2018 Promoters 69.14 68.14 67.62 67.33 Pledged 0 0 0 0 FII/FPI 0.73 0.88 0.89 0.92 Total DII 8.83 8.94 8.88 9.04